DarquenneC: Aerosol deposition in health and disease. J Aerosol Med Pulm Drug Deliv. 2012; 25:140–147.
2.
LaubeBL, JanssensHM, de JonghFH, DevadasonSG, DhandR, DiotP, EverardML, HorvathI, NavalesiP, VoshaarT, and ChrystynH: What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011; 37:1308–1331.
3.
DolovichMA: Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. Respir Care. 2000; 45:597–608.
4.
LavoriniF, PedersenS, and UsmaniOS: Dilemmas, confusion, and misconceptions related to small airways directed therapy. Chest. 2017; 151:1345–1355.
5.
MitchellJ, CopleyM, SizerY, RussellT, and SolomonD: Adapting the Abbreviated Impactor Measurement (AIM) concept to make appropriate inhaler aerosol measurements to compare with clinical data: A scoping study with the “Alberta” idealized throat (AIT) inlet. J Aerosol Med Pulm Drug Deliv. 2012; 25:188–197.
